Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive protein

Atherosclerosis

Volumn 176, Issue 2, 2004, Pages 297-301

  Zeltser, David ^a   Rogowski, Ori ^a   Mardi, Tamar ^a   Justo, Daniel ^a   Tolshinsky, Tatiana ^a   Goldin, Yelena ^a   Burke, Michael ^a   Deutsch, Varda ^a   Berliner, Shlomo ^a   Shapira, Itzhak ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Atherothrombosis; C reactive protein; Low grade inflammation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THROMBOSIS;

ADULT; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; RISK FACTORS; SEX FACTORS; SMOKING; THROMBOSIS;

EID: 5644244407     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.04.015     Document Type: Article

References (14)

1. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143
2. Ridker P.M. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation. 105:2002;2-4
3. Lefer D.J. Statins as potent antiinflammatory drugs. Circulation. 106:2002;2041-2042
4. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 103:2001;1813-1818
5. Woodward M., Lowe G.D.O., Rumley A., et al. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. Eur. Heart J. 19:1998;55-62
6. Erikssen G., Liestol K., Bjornholt J.V., Stormorken H., Thaulow E., Erikssen J. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease and mortality. Eur. Heart J. 21:2000;1614-1620
7. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 279:1998;1477-1482
8. Sabatine M.S., Morrow D.A., Cannon C.P., Murphy S.A., Demopoulos L.A., DiBattiste P.M., et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. A TACTICS-TIMI 18 substudy. J. Am. Colloid Cardiol. 40:2002;1761-1768
9. International Committee for Standardization in Hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 1965;2:235-54.
10. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. Basel. 17:1957;237-246
11. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45:1999;2136-2141
12. Ridker P.M., Rifai N., Rose L., Burning J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347:2002;1557-1565
13. Engstrom G., Lind P., Hedblad B., Hedblad B., Stavenow I., Janzon L., et al. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation. 105:2002;2632-2637
14. Brown D.A., Breit S.N., Fairlie W.D., Bauskin A.R., Liu T., Ridker P.M. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet. 359:2002;2159-2163